CN107703216A - A kind of method of the HG of quick detection tumor tissues 2 accumulations - Google Patents
A kind of method of the HG of quick detection tumor tissues 2 accumulations Download PDFInfo
- Publication number
- CN107703216A CN107703216A CN201610637196.4A CN201610637196A CN107703216A CN 107703216 A CN107703216 A CN 107703216A CN 201610637196 A CN201610637196 A CN 201610637196A CN 107703216 A CN107703216 A CN 107703216A
- Authority
- CN
- China
- Prior art keywords
- accumulations
- tumor tissues
- quick detection
- centrifuge
- detection tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F16/00—Information retrieval; Database structures therefor; File system structures therefor
- G06F16/90—Details of database functions independent of the retrieved data types
- G06F16/903—Querying
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N2030/062—Preparation extracting sample from raw material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N2030/067—Preparation by reaction, e.g. derivatising the sample
Landscapes
- Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Theoretical Computer Science (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- General Engineering & Computer Science (AREA)
- Computational Linguistics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
本发明属于生物技术领域,涉及一种快速检测肿瘤组织致癌代谢物2‑羟基戊二酸2‑HG累积的方法,本方法中将获得肿瘤组织样品,置于离心管中,加入预冷纯甲醇,匀浆机研磨静置后14000 rpm离心,取上清转移至玻璃瓶中,真空干燥离心机充分干燥后加入衍生化试剂MTBSTFA,70℃放置,室温冷却,上机,Agilent 7890A‑5975C;色谱柱为HP‑5MS,载气为高纯氦气,采用NIST数据库搜索和标准品验证双结合的方式对2‑HG鉴定。检测结果显示,采用本发明的检测方法在术中检测脑组织中是否存在2‑HG高水平累积,有助于实现IDH1突变胶质瘤的快速鉴别诊断,并为术后的个体化治疗提供重要指导信息。The invention belongs to the field of biotechnology, and relates to a method for rapidly detecting the accumulation of tumor tissue carcinogenic metabolite 2-hydroxyglutaric acid 2-HG. In the method, a tumor tissue sample is obtained, placed in a centrifuge tube, and pre-cooled pure methanol is added , centrifuge at 14000 rpm after the homogenizer grinds and stands still, take the supernatant and transfer it to a glass bottle, add the derivatization reagent MTBSTFA after the vacuum drying centrifuge is fully dried, place at 70 ° C, cool at room temperature, and put it on the machine, Agilent 7890A-5975C; The column is HP-5MS, the carrier gas is high-purity helium, and the 2-HG is identified by the combination of NIST database search and standard verification. The test results show that using the detection method of the present invention to detect whether there is a high level of 2-HG accumulation in the brain tissue during the operation will help realize the rapid differential diagnosis of IDH1 mutant gliomas and provide important information for postoperative individualized treatment. guidance information.
Description
技术领域technical field
本发明属于生物技术领域,涉及致癌代谢物2-羟基戊二酸(2-HG),具体涉及一种快速检测肿瘤组织2-HG累积的方法,通过检测肿瘤组织中2-HG累积,有助于IDH1突变的快速诊断。The invention belongs to the field of biotechnology, and relates to carcinogenic metabolite 2-hydroxyglutarate (2-HG), in particular to a method for rapidly detecting the accumulation of 2-HG in tumor tissue. By detecting the accumulation of 2-HG in tumor tissue, it helps For the rapid diagnosis of IDH1 mutations.
背景技术Background technique
现有技术公开了胶质瘤(glioma)是中枢神经系统最常见的肿瘤,其中恶性胶质瘤治愈率低,复发率高,预后极差,目前临床多采用手术后同步放化疗加6个疗程的替莫唑胺(TMZ)化疗,其平均生存期仅为12-15个月。因此,目前临床对于恶性胶质瘤需解决的难题是寻找早诊早治的方法。The prior art discloses that glioma is the most common tumor of the central nervous system, among which the cure rate of malignant glioma is low, the recurrence rate is high, and the prognosis is extremely poor. At present, synchronous radiotherapy and chemotherapy after surgery plus 6 courses of treatment are mostly used clinically Temozolomide (TMZ) chemotherapy, the average survival period is only 12-15 months. Therefore, the current clinical problem to be solved for malignant glioma is to find a method for early diagnosis and early treatment.
目前临床实践中,对于一些诊断不明确的病灶需要进行立体定向穿刺活检,典型者比较容易诊断,但实际操作中往往术中冰冻切片病理并不典型,病理科医生只能观察到胶质增生,而胶质增生在低级别胶质瘤、正常脑组织、炎症、部分淋巴瘤等均可出现。虽然突变型IDH1免疫组化染色可鉴别胶质瘤和其他情况,但一般需要5-7天,耗时长,且无法实现术中判断,有时甚至需要反复穿刺,增加病人负担和手术风险。In current clinical practice, stereotaxic biopsy is required for some lesions that are not clearly diagnosed. Typical cases are easier to diagnose. However, in practice, the pathology of frozen sections during surgery is often not typical, and pathologists can only observe gliosis. Gliosis can occur in low-grade glioma, normal brain tissue, inflammation, and some lymphomas. Although mutant IDH1 immunohistochemical staining can differentiate glioma from other conditions, it usually takes 5-7 days, which takes a long time, and intraoperative judgment cannot be realized, and sometimes even repeated punctures are required, which increases the burden on patients and the risk of surgery.
研究公开了,在大多数弥漫性人脑胶质瘤中常伴随着异柠檬酸脱氢酶基因(isocitrate dehydrogenase gene)1(IDH1)的突变. 临床实践显示,有着此突变的胶质瘤患者在临床上有良好的预后效果,并且对化疗和靶向治疗更为敏感。,因此. IDH1突变是胶质瘤一个重要的分子分型标记;IDH催化异柠檬酸氧化脱羧,生成a -酮戊二酸(a-KG),突变型IDH在丧失其正常酶活性的同时,以a -KG 为底物,生成致癌代谢物2-羟基戊二酸(2-HG)。通常,2-HG在正常脑组织中水平很低,而在IDH1突变的胶质瘤中高度累积,相关研究表明,IDH1突变细胞依赖2-HG维持其致癌特性。因此,IDH1突变快速检测,将有助于鉴别诊断胶质瘤,并利于个体化治疗方案的制定和优化,临床意义重大。基于此,本申请的发明人拟提供一种快速检测肿瘤组织2-HG累积的方法,通过检测肿瘤组织中2-HG累积,将实现IDH1突变的快速诊断。Studies have disclosed that most diffuse human gliomas are often accompanied by mutations of isocitrate dehydrogenase gene 1 (IDH1). Clinical practice shows that patients with gliomas with this mutation have It has a good prognostic effect and is more sensitive to chemotherapy and targeted therapy. , therefore. IDH1 mutation is an important molecular typing marker for glioma; IDH catalyzes the oxidative decarboxylation of isocitrate to generate a-ketoglutarate (a-KG), while the mutant IDH loses its normal enzyme activity, Using α-KG as a substrate, the carcinogenic metabolite 2-hydroxyglutarate (2-HG) is generated. Normally, 2-HG is low in normal brain tissue but highly accumulated in IDH1-mutant gliomas. Related studies have shown that IDH1-mutant cells rely on 2-HG to maintain their oncogenic properties. Therefore, the rapid detection of IDH1 mutation will help in the differential diagnosis of glioma, and facilitate the formulation and optimization of individualized treatment plan, which is of great clinical significance. Based on this, the inventors of the present application intend to provide a method for rapid detection of 2-HG accumulation in tumor tissue, by detecting the accumulation of 2-HG in tumor tissue, the rapid diagnosis of IDH1 mutation will be realized.
发明内容Contents of the invention
本发明的目地是针对现有技术的现状,提供一种快速检测肿瘤组织2-HG累积的方法,通过检测肿瘤组织中2-HG累积,为实现IDH1突变的快速诊断提供依据并为术后的个体化治疗提供重要指导信息。The purpose of the present invention is to provide a method for rapid detection of 2-HG accumulation in tumor tissue in view of the status quo of the prior art. By detecting the accumulation of 2-HG in tumor tissue, it provides a basis for the rapid diagnosis of IDH1 mutation and provides a basis for postoperative diagnosis. Individualized treatment provides important guiding information.
具体的,本发明的快速检测肿瘤组织2-HG累积的方法,其包括步骤:Specifically, the method for rapidly detecting tumor tissue 2-HG accumulation of the present invention comprises the steps of:
1.获得肿瘤组织样品,置于离心管中;1. Obtain tumor tissue samples and place them in centrifuge tubes;
2.向上述离心管中加入预冷纯甲醇;2. Add pre-cooled pure methanol to the above centrifuge tube;
3.匀浆机研磨1 min,静置片刻;3. Grind with a homogenizer for 1 min and let stand for a while;
4.14000rpm离心;4. 14000rpm centrifugal;
5.取上清,转移至玻璃瓶中,真空干燥离心机充分干燥;5. Take the supernatant, transfer it to a glass bottle, and fully dry it in a vacuum drying centrifuge;
6.加入衍生化试剂MTBSTFA,70℃放置;6. Add the derivatization reagent MTBSTFA and place at 70°C;
7.室温冷却,上机(Agilent 7890A-5975C;色谱柱为HP-5MS,载气为高纯氦气。7. Cool at room temperature, and put it on the machine (Agilent 7890A-5975C; the chromatographic column is HP-5MS, and the carrier gas is high-purity helium.
采用NIST数据库搜索和标准品验证双结合的方式对2-HG鉴定。2-HG was identified by a combination of NIST database search and standard verification.
本申请中,对术中获得的离体的胶质瘤脑组织进行了快速检测,检测结果显示,采用本发明的检测方法,在术中检测脑组织中是否存在2-HG高水平累积,有助于实现IDH1突变胶质瘤的快速鉴别诊断,并为术后的个体化治疗提供重要指导信息。In this application, rapid detection was performed on the isolated glioma brain tissue obtained during the operation, and the detection results showed that, by using the detection method of the present invention, it is possible to detect whether there is a high level of 2-HG accumulation in the brain tissue during the operation. It helps to realize the rapid differential diagnosis of IDH1 mutant glioma, and provides important guidance information for postoperative individualized treatment.
本发明的检测肿瘤组织2-HG累积的方法的优点有:The advantages of the method for detecting tumor tissue 2-HG accumulation of the present invention are:
1,对2-HG进行检测的同时可以为诊断IDH1突变提供具有特异性的参考数据;1. While detecting 2-HG, it can provide specific reference data for the diagnosis of IDH1 mutation;
2,对于一些诊断不明确的病灶不需要反复穿刺,明显降低病人危险风险;2. Repeated puncture is not required for some lesions with unclear diagnosis, which significantly reduces the risk of patients;
3、检测时间快速,术中即可获得初步判断,只需判断是否有2-HG累积,进而进行鉴别是否为胶质瘤,或是IDH1突变的胶质瘤,为临床判断提供重要信息。3. The detection time is fast, and a preliminary judgment can be obtained during the operation. It only needs to judge whether there is 2-HG accumulation, and then distinguish whether it is a glioma or a glioma with an IDH1 mutation, which provides important information for clinical judgment.
为了便于理解,以下将通过具体的实施例对本发明的方法进行详细地描述。需要特别指出的是,具体实例仅是为了说明,显然本领域的普通技术人员可以根据本文说明,在本发明的范围内对本发明做出各种各样的修正和改变,这些修正和改变也纳入本发明的范围内。For ease of understanding, the method of the present invention will be described in detail below through specific examples. It should be pointed out that the specific examples are only for illustration. Obviously, those skilled in the art can make various amendments and changes within the scope of the present invention according to the description herein, and these amendments and changes are also incorporated into within the scope of the present invention.
具体实施方式detailed description
实施例1Example 1
对胶质瘤术中获得的离体的胶质瘤脑组织进行了快速检测,将肿瘤组织样品切下25-30μg,置于1.5ml离心管中;向所述离心管中加入100μl预冷纯甲醇;手持匀浆机研磨1min,静置片刻;14000rpm离心10min;取上清40μl,转移至V型底GC专用玻璃瓶中,真空干燥离心机充分干燥,耗时约25min;.在通风厨中加入衍生化试剂40μl MTBSTFA,盖紧瓶盖,70℃放置25min; 室温自然冷却,上机,Agilent 7890A-5975C;色谱柱为HP-5MS,载气为高纯氦气。采用NIST数据库搜索和标准品验证双结合的方式对2-HG鉴定。The isolated glioma brain tissue obtained during glioma surgery was rapidly detected, and 25-30 μg of the tumor tissue sample was excised and placed in a 1.5ml centrifuge tube; 100 μl of pre-cooled pure Methanol; Grind with a hand-held homogenizer for 1 min, and let stand for a while; Centrifuge at 14,000 rpm for 10 min; Take 40 μl of the supernatant, transfer it to a V-bottom GC special glass bottle, and fully dry it in a vacuum drying centrifuge, which takes about 25 min;. In a fume hood Add 40 μl of derivatization reagent MTBSTFA, tightly cap the bottle, and place it at 70°C for 25 minutes; let it cool naturally at room temperature, and put it on the machine, Agilent 7890A-5975C; the chromatographic column is HP-5MS, and the carrier gas is high-purity helium. 2-HG was identified by a combination of NIST database search and standard verification.
检测结果显示,采用本发明的检测方法,在术中检测脑组织中是否存在2-HG高水平累积,有助于实现IDH1突变胶质瘤的快速鉴别诊断,并为术后的个体化治疗提供重要指导信息。The test results show that using the detection method of the present invention to detect whether there is a high-level accumulation of 2-HG in the brain tissue during the operation is helpful to realize the rapid differential diagnosis of IDH1 mutant glioma, and provides a basis for individualized treatment after the operation. Important Guidance Information.
Claims (7)
- A kind of 1. method of quick detection tumor tissues 2-HG accumulations, it is characterised in that it includes step: 1)Obtain tumor group Tissue samples, it is placed in centrifuge tube;2)The pure methanol of precooling is added into above-mentioned centrifuge tube;3)Refiner grinds 1min, stands a moment;4)14000rpm is centrifuged;5)Supernatant is taken, is transferred in vial, vacuum drying centrifuge is fully dried;6)Add derivatization reagent MTBSTFA, 70 DEG C of placements;7)Room temperature cools down, upper machine, Agilent 7890A-5975C;Chromatographic column is HP-5MS, and carrier gas is high-purity helium.
- 2. the method for the quick detection tumor tissues 2-HG accumulations as described in claim 1, it is characterised in that in this method, adopt 2-HG is identified with the mode of NIST database search and standard items checking double combination.
- 3. the method for the quick detection tumor tissues 2-HG accumulations as described in claim 1, it is characterised in that described step 1) In, neoplasmic tissue sample is 25-30 μ g, is placed in 1.5ml centrifuge tubes.
- 4. the method for the quick detection tumor tissues 2-HG accumulations as described in claim 1, it is characterised in that described step 2) In, the 100 pure methanol of μ l precoolings are added into centrifuge tube.
- 5. the method for the quick detection tumor tissues 2-HG accumulations as described in claim 1, it is characterised in that described step 3) In, refiner grinding 1min is held, stands a momentThe method of quick detection tumor tissues 2-HG accumulations as described in claim 1, it is characterised in that described step 4) In, 14000rpm centrifugations 10min.
- 6. the method for the quick detection tumor tissues 2-HG accumulations as described in claim 1, it is characterised in that described step 5) In, the μ l of supernatant 40 are taken, are transferred in the GC special glass bottles of V-type bottom, vacuum drying centrifuge dries 25min.
- 7. the method for the quick detection tumor tissues 2-HG accumulations as described in claim 1, it is characterised in that described step 6) In, the μ l MTBSTFA of derivatization reagent 40 are added in ventilating kitchen, cover tightly bottle cap, 70 DEG C of placement 25min.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610637196.4A CN107703216A (en) | 2016-08-07 | 2016-08-07 | A kind of method of the HG of quick detection tumor tissues 2 accumulations |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610637196.4A CN107703216A (en) | 2016-08-07 | 2016-08-07 | A kind of method of the HG of quick detection tumor tissues 2 accumulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107703216A true CN107703216A (en) | 2018-02-16 |
Family
ID=61168249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610637196.4A Pending CN107703216A (en) | 2016-08-07 | 2016-08-07 | A kind of method of the HG of quick detection tumor tissues 2 accumulations |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107703216A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022165917A1 (en) * | 2021-02-05 | 2022-08-11 | 山东大学 | Transcriptional regulation factor specifically responsive to d-2-hydroxyglutaric acid and application thereof |
| CN115248272A (en) * | 2022-06-08 | 2022-10-28 | 深检集团(深圳)医学检验实验室 | Method for detecting alpha-ketoglutaric acid and chiral 2-hydroxyglutaric acid |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011247869A (en) * | 2010-04-27 | 2011-12-08 | Kobe Univ | Inspection method of specific disease using metabolome analysis method |
| US20120040383A1 (en) * | 2010-08-12 | 2012-02-16 | Wei Jia | Methods and Kits Relating To Metabolite Biomarkers For Colorectal Cancer |
| WO2016161525A1 (en) * | 2015-04-10 | 2016-10-13 | Gregor Reid | Diagnosis of bacterial vaginosis |
-
2016
- 2016-08-07 CN CN201610637196.4A patent/CN107703216A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011247869A (en) * | 2010-04-27 | 2011-12-08 | Kobe Univ | Inspection method of specific disease using metabolome analysis method |
| US20120040383A1 (en) * | 2010-08-12 | 2012-02-16 | Wei Jia | Methods and Kits Relating To Metabolite Biomarkers For Colorectal Cancer |
| WO2016161525A1 (en) * | 2015-04-10 | 2016-10-13 | Gregor Reid | Diagnosis of bacterial vaginosis |
Non-Patent Citations (2)
| Title |
|---|
| 姚卫峰等: "细胞代谢组学及其应用", 《中国临床药理学与治疗学》 * |
| 张辰辰 等: "基于代谢组学的细胞内源性代谢物研究进展", 《药学学报》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022165917A1 (en) * | 2021-02-05 | 2022-08-11 | 山东大学 | Transcriptional regulation factor specifically responsive to d-2-hydroxyglutaric acid and application thereof |
| CN115248272A (en) * | 2022-06-08 | 2022-10-28 | 深检集团(深圳)医学检验实验室 | Method for detecting alpha-ketoglutaric acid and chiral 2-hydroxyglutaric acid |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Xiao et al. | Cerebrospinal fluid biomarkers for brain tumor detection: clinical roles and current progress | |
| Jones et al. | Circulating biomarkers for glioma: a review | |
| Guo et al. | Isocitrate dehydrogenase mutations in gliomas: mechanisms, biomarkers and therapeutic target | |
| Hemminger et al. | Discovered on gastrointestinal stromal tumours 1 (DOG1) expression in non‐gastrointestinal stromal tumour (GIST) neoplasms | |
| Liu et al. | Genetics and epigenetics of glioblastoma: applications and overall incidence of IDH1 mutation | |
| Park et al. | Quantitative analysis of cell-free DNA in the plasma of gastric cancer patients | |
| Pu et al. | Elevated expression of exosomal microRNA-21 as a potential biomarker for the early diagnosis of pancreatic cancer using a tethered cationic lipoplex nanoparticle biochip | |
| Feller‐Kopman et al. | Cytology of endobronchial ultrasound‐guided transbronchial needle aspiration: a retrospective study with histology correlation | |
| Rakheja et al. | The emerging role of d-2-hydroxyglutarate as an oncometabolite in hematolymphoid and central nervous system neoplasms | |
| Mijnes et al. | Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: RBBP8/CtIP is almost exclusively methylated in bladder cancer | |
| Shaozhang et al. | Comparison of ARMS and direct sequencing for detection of EGFR mutation and prediction of EGFR-TKI efficacy between surgery and biopsy tumor tissues in NSCLC patients | |
| Friedman et al. | Tapping into the genome: the role of CSF ctDNA liquid biopsy in glioma | |
| CN107703216A (en) | A kind of method of the HG of quick detection tumor tissues 2 accumulations | |
| Akutsu et al. | Lymph node dissection for esophageal cancer | |
| Mo et al. | Use of serum circulating CCNB2 in cancer surveillance | |
| CN105002283A (en) | QPCR composition and kit for detecting human c-kit gene mutation | |
| Su et al. | Dynamic alterations of plasma cell free DNA in response to chemotherapy in children with neuroblastoma | |
| Gu et al. | Serum level of interleukin‐35 as a potential prognostic factor for gastric cancer | |
| Lasota et al. | New mechanisms of mTOR pathway activation in KIT-mutant malignant GISTs | |
| CN108303536A (en) | The quickly kit of detection tumor tissues 2-HG accumulations | |
| CN113186296B (en) | Focal adhesion kinase splice isomer and application thereof | |
| Xu et al. | Survivin rs9904341 (G> C) polymorphism contributes to cancer risk: an updated meta-analysis of 26 studies | |
| Sun et al. | Epidermal Growth Factor Receptor Mutation Status and Adjuvant Chemotherapy in Resected Advanced Non–Small-Cell Lung Cancer | |
| Zhang et al. | Occurrence of low frequency PIK3CA and AKT2 mutations in gastric cancer | |
| CN113186293A (en) | Nucleic acid composition, kit and detection method for detecting lung cancer related gene methylation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180216 |